The ARMOR clinical trial investigates FMT from young, active donors to older adults to enhance muscle, cognitive, and metabolic health, addressing gut dysbiosis for aging resilience. A groundbreaking ...
Recent studies show that targeting engrams with partial reprogramming factors improves memory in mouse models, offering a potential therapy for Alzheimer’s and age-related cognitive decline. New...
New research on position effect variegation in Drosophila reveals epigenetic aging markers, linking heterochromatin stability to longevity and informing anti-aging therapies. Recent studies show PEV i...
A 2024 study in Nature Aging shows transferring young gut bacteria to aged mice rejuvenates intestinal stem cells via Wnt signaling, suggesting FMT’s potential for age-related disorders. Recent ...
Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
Emerging senolytic treatments target cellular senescence to reduce inflammation and improve kidney function in diabetic patients, with recent clinical trials confirming safety and hinting at efficacy....
Recent studies show FMT from young donors improves gut health and cognitive function in aging, with FDA updates and probiotic innovations paving the way for scalable therapies. New research reveals FM...
Recent research indicates shingles vaccination may reduce inflammation and epigenetic aging in older adults, potentially lowering risks of dementia and cardiovascular diseases. Emerging evidence shows...
Recent studies show that regular exercise combats immunosenescence by boosting immune cell activity, reducing inflammation, and improving metabolic health in older adults. New research highlights exer...
Analysis of metabolites like taurine and NAD+ in aging research, highlighting animal studies, human trials, and ethical considerations for longevity strategies. Emerging research on metabolites reveal...
